COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,154 Articles (22,703 medRxiv, 8,451 bioRxiv)

Most recent first Previous |  Page 2137: Articles 21361-21370  | Next

Effect of park use and landscape structure on COVID-19 transmission rates
Johnson, T. F., Hordley, L. A., Greenwell, M. P., Evans, L. C.
10.1101/2020.10.20.20215731 — Posted: 2020-10-21
Modelling the dispersion of SARS-CoV-2 on a dynamic network graph
Bryant, P., Elofsson, A.
10.1101/2020.10.19.20215046 — Posted: 2020-10-21
From multiplex serology to serolomics: A novel approach to the antibody response against the SARS-CoV-2 proteome
Butt, J., Murugan, R., Hippchen, T., Olberg, S., van Straaten, M., Wardemann, H., Stebbins, E., Kraeusslich, H.-G., Bartenschlager, R., Brenner, H., Laketa, V., Schoettker, B., Mueller, B., Merle, U., Waterboer, T.
10.1101/2020.10.19.20214916 — Posted: 2020-10-21
Efficacy of stay-at-home policy and transmission of COVID-19 in Toronto, Canada: a mathematical modeling study
Yuan, P., Li, J., Aruffo, E., Li, Q., Zheng, T., Ogden, N., Sander, B., Heffernan, J., Gatov, E., Gournis, E., Collier, S., Tan, Y., Li, J., Arino, J., Belair, J., Watmough, J., Kong, J. D., Moyles, I., Zhu, H.
10.1101/2020.10.19.20181057 — Posted: 2020-10-21
Extending the range of COVID-19 risk factors ina Bayesian network model for personalised riskassessment
Prodhan, G.
10.1101/2020.10.20.20215814 — Posted: 2020-10-21 Discussion: Onsite
SI epidemic model applied to COVID-19 data in mainland China
Demongeot, J., Griette, Q., magal, p.
10.1101/2020.10.19.20214528 — Posted: 2020-10-21
Percentage HScore confirms low incidence of secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients
Ardern-Jones, M. R., Stammers, M., Phan, H. T. T., Borca, F., Koutalopoulou, A., Teo, Y., Batchelor, J., Smith, T., Duncombe, A.
10.1101/2020.10.19.20214015 — Posted: 2020-10-21
Accuracy of Healthcare Professionals Nasopharyngeal Swab Technique in SARS-CoV-2 Specimen Collection
Woods, R., Walsh, M., Nwaokorie, K., Crowley, J., Lacy, P., de Barra, E.
10.1101/2020.10.19.20213140 — Posted: 2020-10-21
Low-Cost Manually Assembled Open Source Reader for Isothermal Pathogen Detection from Saliva using RT-LAMP: SARS-CoV-2 Use Case
Bramley, J. C., Waligorski, J. E., Kremitzki, C. K., Liebeskind, M. J., Yenkin, A., Xu, E., Lalli, M. A., O'Halloran, J. A., Mudd, P. A., House, S., Mitra, R., Milbrandt, J. D., Buchser, W. J.
10.1101/2020.10.19.20215319 — Posted: 2020-10-21
A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
Dubee, V., Roy, P.-M., Vielle, B., Parot-Schinkel, E., Blanchet, O., Darsonval, A., Lefeuvre, C., Abbara, C., Boucher, S., Devaud, E., Robineau, O., Rispal, P., Guimard, T., D'Anglejan, E., Diamantis, S., Custaud, M.-A., Pellier, I., Mercat, A.
10.1101/2020.10.19.20214940 — Posted: 2020-10-21 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).